Type 2 diabetes mellitus (T2DM) has been declared an epidemic by the World Health Organization. 1 Treatment of T2DM individuals places considerable economic strain on health care systems worldwide. 2-4 However, it is hypothesized that early detection of T2DM can prompt intervention to delay the onset of symptoms, 5,6 and thus potentially reduce costs and improve quality of life. Insulin sensitivity (SI) is widely regarded as one of the better measures of the progression of an individual from normal glucose tolerance (NGT) to T2DM. 7-9 However, accurate determination of SI usually requires tests that are relatively clinically intense and expensive. 10 The "gold standard" test used to determine SI is the hyper-insulinemic euglycemic clamp test (EIC), which typically takes place over 2.5 to 4 hours, and requires a large number of blood samples (at least 20) to be drawn. 11 Hence other diagnostic tests are recommended in clinical practice. 12 One such test is the 2-hour Oral Glucose Tolerance Test (OGTT), which typically assesses glucose levels 2 hours after ingestion of a glucose drink. If the 2-hour glucose is in excess of 200 mg/dl a preliminary diagnoses of Type 2 Diabetes can be made. 12 However, due to the lack of an SI measurement, this process can only diagnose someone who already has T2DM, or, at lower glycemic thresholds, someone who is already displaying impaired glucose tolerance. Thus, it is not able to estimate increased risk and could not effectively prompt early preventative measures. Means do exist to approximate SI based on OGTT data. The Matsuda Index requires 4 blood samples at t = 0, 30, 60, and 120 to be taken and assayed for both glucose and insulin. 13 As such, it is far more expensive and clinically intensive than the HOMA or 2-hour OGTT 532490D STXXX10.